Table 1.
Primer sequences used in this study.
| Primer | Forward (5′–3′) | Reverse (5′–3′) | Length (bp) | Accession No. |
|---|---|---|---|---|
| MMP-3 | TGGGAAGCCAGTGGAAATG | CCATGCAATGGGTAGGATGAG | 81 | NM_133523 |
| TIMP-1 | CTGAGAAGGGCTACCAGAGC | GTCATCGAGACCCCAAGGTA | 88 | NM_053819 |
| NF-κB | CACTCTCTTTTTGGAGGT | TGGATATAAGGCTTTACG | 206 | NM_199267 |
| IL-1β | CACCTCTCAAGCAGAGCACAGA | ACGGGTTCCATGGTGAAGTC | 81 | NM_031512 |
| TNF-α | TGGGCTCATACCAGGGCTTGAG | CGTCAGCCGATTTGCCATTTC | 116 | NM_012675 |
| HO-1 | GGTGTCCAGGGAAGGCTTTA | GGGGCATAGACTGGGTTCTG | 105 | NM_012580.2 |
| β-actin | TGTTGCCCTAGACTTCGAGCA | GGACCCAGGAAGGAAGGCT | 155 | NM_007393 |
MMP-3: matrix metalloproteinase-3; TIMP-1: tissue inhibitor of metalloproteinase-1; NF-κB: nuclear factor-κB; IL-1β: interleukin-1β; TNF-α: tumor necrosis factor-α; HO-1: heme oxygenase-1.